Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the standoff at Standing Rock or news about the movements fighting for peace, racial and economic justice, immigrant rights and LGBTQ equality. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How is this possible? Only with your support. If every visitor to this site in December gave just $10 we could cover our basic operating costs for 2017. Pretty exciting, right? So, if you've been waiting to make your contribution to Democracy Now!, today is your day. It takes just a couple of minutes to make sure that Democracy Now! is there for you and everybody else in 2017.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Topics

Monsanto's Revolving Door

StoryJuly 23, 1999
Watch iconWatch Full Show

Last month, Monsanto’s G.D. Searle pharmaceuticals unit named Michael A.Friedman as its new clinical-research chief. In his new capacity, Dr. Friedman will direct strategy and execution of clinical research on new drugs at Searle. Friedman was acting commissioner of the FDA, the Food and Drug Administration, from February 1997 through November 1998, and also served as lead deputy operations commissioner of the federal agency. And from 1985 to 1995 he held senior positions at the National Cancer Institute. Donna Shalala, secretary of Health and Human Services, credited Friedman with having played a major role in speeding up FDA approval of cancer drugs.

But Dr. Friedman is not the only person to leave a government post for Monsanto. It seems that Monsanto and the Clinton Administration have a close relationship, a revolving door. A growing number of government officials are going to the biotech giant as lobbyists and officers in the company.

Guest:

  • Mike Hansen, researcher at Consumer Policy Institute, a division of Consumers Union, publisher of Consumer Reports. Call: 914.378.2452.

Related links:


The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.

Make a donation